Department of Cardiovascular Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
Nutrients. 2023 Feb 1;15(3):748. doi: 10.3390/nu15030748.
Cardiovascular diseases and liver diseases are closely related. Non-alcoholic fatty liver disease has the same risk factors as those for atherosclerotic cardiovascular disease and may also be a risk factor for atherosclerotic cardiovascular disease on its own. Heart failure causes liver fibrosis, and liver fibrosis results in worsened cardiac preload and congestion. Although some previous reports regard the association between cardiovascular diseases and liver disease, the management strategy for liver disease in patients with cardiovascular diseases is not still established. This review summarized the association between cardiovascular diseases and liver disease. In patients with non-alcoholic fatty liver disease, the degree of liver fibrosis progresses with worsening cardiovascular prognosis. In patients with heart failure, liver fibrosis could be a prognostic marker. Liver stiffness assessed with shear wave elastography, the fibrosis-4 index, and non-alcoholic fatty liver disease fibrosis score is associated with both liver fibrosis in patients with liver diseases and worse prognosis in patients with heart failure. With the current population ageing, the importance of management for cardiovascular diseases and liver disease has been increasing. However, whether management and interventions for liver disease improve the prognosis of cardiovascular diseases has not been fully understood. Future investigations are needed.
心血管疾病和肝脏疾病密切相关。非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病的危险因素相同,自身也可能是动脉粥样硬化性心血管疾病的一个危险因素。心力衰竭导致肝纤维化,而肝纤维化导致心脏前负荷和充血恶化。尽管一些先前的报告涉及心血管疾病和肝脏疾病之间的关联,但心血管疾病患者肝脏疾病的管理策略尚未确定。本综述总结了心血管疾病和肝脏疾病之间的关联。在非酒精性脂肪性肝病患者中,随着心血管预后的恶化,肝纤维化的程度也在进展。在心力衰竭患者中,肝纤维化可能是一个预后标志物。应用剪切波弹性成像评估的肝硬度、纤维化-4 指数和非酒精性脂肪性肝病纤维化评分与肝病患者的肝纤维化以及心力衰竭患者的预后恶化均相关。随着当前人口老龄化,对心血管疾病和肝脏疾病管理的重要性日益增加。然而,对于肝脏疾病的管理和干预是否能改善心血管疾病的预后尚未完全了解。需要进一步研究。